To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Rome Foundation Working T… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome

Journal article
Authors G. Barbara
M. Grover
P. Bercik
M. Corsetti
U. C. Ghoshal
Lena Öhman
M. Rajilic-Stojanovic
Published in Gastroenterology
Volume 156
Issue 1
Pages 46-+
ISSN 0016-5085
Publication year 2019
Published at Institute of Biomedicine, Department of Microbiology and Immunology
Pages 46-+
Language en
Links dx.doi.org/10.1053/j.gastro.2018.07...
Keywords Gastrointestinal Infection, Microbiome, Campylobacter, Serotonin, Barrier Function, bile-acid malabsorption, functional gastrointestinal disorders, enterochromaffin cell hyperplasia, placebo-controlled trial, low fodmap, diet, follow-up, bacterial gastroenteritis, mouse model, interstitial-cells, double-blind, Gastroenterology & Hepatology, ewart gt, 1950, bmj-british medical journal, v1, p405, audhary na, 1962, quarterly journal of medicine, v31, p307
Subject categories Gastroenterology and Hepatology

Abstract

BACKGROUND & AIMS: The existence of postinfection irritable bowel syndrome (PI-IBS) has been substantiated by epidemiology studies conducted in diverse geographic and clinical settings. However, the available evidence has not been well summarized, and there is little guidance for diagnosis and treatment of PI-IBS. The ROME Foundation has produced a working team report to summarize the available evidence on the pathophysiology of PI-IBS and provide guidance for diagnosis and treatment, based on findings reported in the literature and clinical experience. METHODS: The working team conducted an evidence-based review of publication databases for articles describing the clinical features (diagnosis), pathophysiology (intestinal sensorimotor function, microbiota, immune dysregulation, barrier dysfunction, enteroendocrine pathways, and genetics), and animal models of PI-IBS. We used a Delphi-based consensus system to create guidelines for management of PI-IBS and a developed treatment algorithm based on published findings and experiences of team members. RESULTS: PI-IBS develops in about 10% of patients with infectious enteritis. Risk factors include female sex, younger age, psychological distress during or before acute gastroenteritis, and severity of the acute episode. The pathogenesis of PI-PBS appears to involve changes in the intestinal microbiome as well as epithelial, serotonergic, and immune system factors. However, these mechanisms are incompletely understood. There are no evidence-based, effective pharmacologic strategies for treatment of PI-IBS. We provide a consensus-based treatment algorithm, based on clinical presentation and potential disease mechanisms. CONCLUSIONS: Based on a systematic review of the literature and team experience, we summarize the clinical features, pathophysiology (from animal models and human studies), and progression of PI-IBS. Based on these findings, we present an algorithm for diagnosis and treatment of PI-IBS based on team consensus. We also propose areas for future investigation.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?